This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n10http://linked.opendata.cz/resource/drugbank/drug/DB08534/identifier/pubchem-compound/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n8http://linked.opendata.cz/resource/drugbank/drug/DB08534/identifier/pubchem-substance/
n13http://linked.opendata.cz/resource/drugbank/drug/DB08534/identifier/drugbank/
n4http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n12http://linked.opendata.cz/resource/drugbank/drug/DB08534/identifier/chemspider/
n11http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n9http://linked.opendata.cz/resource/drugbank/drug/DB08534/identifier/pdb/

Statements

Subject Item
n2:DB08534
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n4:DB08534 n11:DB08534
dcterms:title
5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine
adms:identifier
n8:99445005 n9:SCF n10:21066096 n12:19872591 n13:DB08534
n5:IUPAC-Name
n6:271B616C-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B6172-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B6171-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B616E-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B616F-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B6170-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B616A-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B616B-363D-11E5-9242-09173F13E4C5 n6:271B6168-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B6169-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B6178-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B6179-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B6173-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B6174-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B6176-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B6175-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B6177-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B617D-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B617F-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B6180-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B617C-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B617B-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B617E-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B616D-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B617A-363D-11E5-9242-09173F13E4C5